Marketing analysis of the pharmaceutical market in Ukraine opioid analgesics
Opioid analgesics (OA) are essential medicines, in particularly for pain relief in palliative care. At the same time the problem of availability of this medicines for medical need is common in many countries. Among the causes is limited assortment of OA market.
To research the Ukrainian market of OA the state register of medicines, the registries of US, UK, Sweden, Latvia, Estonia, Hungary, Croatia, the WHO Model List Of Essential Medicines and the International Association of Hospice and Palliative Care (IAHPC) list of essential medicines for palliative care, sales data of marketing company «Business- credit » were analyzed. Methods of system-oriented approach and marketing analysis have been used.
33 OA trade names that are 10 INN and 3 drug combination are registered at the Ukrainian market. The market is dominated by domestic products (69.4%), and injection forms (53%). In comparison with the international market Ukrainian OA market limited in assortment of INN and dosage forms of drugs. There is a perspective for registration morphine oral solution and prolonged release forms, medicines of hydromorphone and oxycodone in different forms, which are recommended by WHO and IAHPC.
Analysis of sales demonstrated that OA market in monetary terms has been increased since 2010 in 1,5. With that the market of injectable analgesics of «Zdorovye Narody», LTD, which is the main part of the market (61,6%), in ampules dropped significantly. Also, the market of nalbuphine in natural and monetary value is growing.
2. Cancer Pain Relief: A Guide to Opioid Availability [Electronic Resource] / World Health Organization. - Geneva, 1996. - Access mode: http://whqlibdoc.who.int/publications/9241544821.pdf
3. Availability of Internationally Controlled Drugs: Ensuring Adequate Access for Medical and Scientific Purposes. Indicable, Adequately Available and Unjustifiable: Report of the International Narcotics Control Board for 2015. - New York: United Nations, International Narcotics Control Board, 2016. - 116 p.
4. Ensuring balance in national policies on controlled substances: guidelines for availability and availability of controlled medicines / World Health Organization. - Geneva, 2011 - 88 p.
5. K. Foley, J. Wagner, D. Joranson et al. Pain control for people with cancer and AIDS // Disease Control Priorities in Developing Countries (2nd edition) - 2006. - P. 981-993.
6. Gubsky Yu.I. Problem of Pain in Palliative Medicine: Social Challenge and Molecular Pharmacology // Pharmacol. and drug toxicology. - 2013. - No. 6 (36). - P. 85-90.
7. Connor S. R., Bermedo M. C. Global Atlas of Palliative Care at the End of Life. - Geneva, Switzerland / London, UK: World Health Organization, Worldwide Palliative Care Alliance, 2014 - 112 p.
8. De Lima L., Krakauer E., Lorenz K. et al. Ensuring palliative medicine availability: the development of J. J. Pain Symptom Manage. - 2007. - N 33. - P. 521-526.
9. Silbermann M. Current trends in opioid consumption globally and in the Middle East countries // J. Pediatr. Hematol./Oncol. - 2011. - N 33 (1). - P. 1-5.
10. State Register of Medicinal Products of Ukraine [Electronic resource]: Information Fund / State Expert Center of the Ministry of Health of Ukraine. - Mode of access: http://www.drlz.kiev.ua/
11. Drug database [Electronic resource] // National Institute of Pharmacy and Nutrition in Budapest. - Access mode: https://www.ogyei.gov.hu/drug_database/
12. Transmission Facility - Utökad sökning [Electronic resource] // Medical Products Agency (Lakemedelsverket), Sweden / - Access mode: https://lakemedelsverket.se/LMF//
13. Medicinal product register of the Republic of Latvia [Electronic resource] // State Agency of Medicines of the Republic of Latvia - Access mode: https://www.zva.gov.lv/zalu-registrs/?iss=1&lang= en & q = N02A & ON = & SN = & NAC = on & RN = & ESC = on & AK = & SAT = on & RA = & DEC = on & LB = & PIM = on & MFR = & MDO = & IK =
14. Medicinal products authorized in Estonia [Electronic resource] // Agency of Medicine, Republic of Estonia. - Access mode: http://126.96.36.199/register/register.php?keel=eng&inim_vet=inim
15. Medicinal Products Database [Electronic resource] // Agency for Medicinal Products and Medical Devices of Croatia - Access mode: http://www.halmed.hr/?ln=en&w=lijekovi#rezultati
16. Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations [U.S. Food and Drug Administration. - 2016 - Access Mode: http://www.accessdata.fda.gov/scripts/cder/ob/
17. Pharmaceuticals - Community Register [European Resource] // European Commission / - Access Mode: http://ec.europa.eu/health/documents/community-register/html/atc.htm
18. The electronic Medicines Compendium. - Access mode: https://www.medicines.org.uk/emc/about-the-emc
19. WHO Model List of Essential Medicines: 19th List (April 2015, Amended November 2015) [Electronic Resource] / World Health Organization. - Access mode: http://www.who.int/medicines/publications/ essentialmedicines / EML2015_8-May-15.pdf
20. On approval of the maximum permissible amount of narcotic drugs, psychotropic substances and precursors contained in preparations [Electronic resource]: Resolution of the Cabinet of Ministers of Ukraine No. 1203 dated October 10, 2007. - Access mode: http://zakon5.rada.gov.ua/laws/show/1203-2007-%D0%BF
21. Palliative care for adults: strong opioids for pain relief. Clinical guideline // National Institute for Health and Care Excellence. - 2012. - Access mode: https://www.nice.org.uk/guidance/cg140?unlid= 7810781802015112611725
22. Instructions for medical use of the preparation NALBUFIN SERB. [Electronic resource] // State Registry of Medicines of Ukraine: Information Fund / State Expert Center of the Ministry of Health of Ukraine. - Mode of access: http://www.drlz.kiev.ua/
This work is licensed under a Creative Commons Attribution 4.0 International License.